CIK 0001035354 · Non-accelerated filer<br>Smaller reporting company
Eloxx Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ELOX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 841368850
- Phone
- 781-577-5300
- Business address
- P.O. BOX 274, ARLINGTON, MA, 02476
- Former names
- Sevion Therapeutics, Inc., SENESCO TECHNOLOGIES INC, NAVA LEISURE USA INC
- EFFECT Other Notice of Effectiveness
- EFFECT Other Notice of Effectiveness
- CERT Other Certification
- 8-A12B Other Registration of Securities
- DEF 14C Other DEF 14C
- PRE 14C Other PRE 14C
- DRS Other Draft Registration Statement
- NT 10-Q Other NT 10-Q
- NT 10-Q Other NT 10-Q
- NT 10-K Other NT 10-K
- SEC STAFF ACTION Other SEC Staff Action
- NT 10-Q Other NT 10-Q
- NT 10-Q Other NT 10-Q
- NT 10-Q Other NT 10-Q
- NT 10-K Other NT 10-K
- 25-NSE Other Notification of Removal from Listing
- S-8 Other Securities Offered to Employees in Benefit Plans
- DEFA14A Proxy Proxy Materials
- CT ORDER Other Confidential Order
- S-8 Other Securities Offered to Employees in Benefit Plans
Page 1 of 7 · 137 filings